Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.
Younes A; Bartlett NL; Leonard JP; Kennedy DA; Lynch CM; Sievers EL; Forero-Torres A; The New England Journal Of Medicine, 2010, vol. 363, issue 19, p 1812, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation